CHRN
ChronoScale CorporationNASDAQTECHNOLOGYINFORMATION TECHNOLOGY SERVICES
Key Statistics
Market Cap
$2.70B
P/E Ratio
—
EPS
$-0.51
Beta
1.03
52W High
$24.00
52W Low
$2.73
50-Day MA
$13.88
200-Day MA
$8.62
Dividend Yield
—
Profit Margin
-86.20%
Forward P/E
—
PEG Ratio
—
About ChronoScale Corporation
Charan Corporation (Ticker: CHRN) is a dynamic player in the biotechnology sector, focusing on innovative solutions that leverage advanced technology for healthcare applications. The company is engaged in the research, development, and commercialization of novel therapeutics designed to address unmet medical needs. With a robust pipeline of products and a commitment to scientific excellence, CHRN aims to improve patient outcomes and establish itself as a leader in the biotechnology landscape. Its strategic collaborations and emphasis on cutting-edge research position the company to capitalize on emerging opportunities within the rapidly evolving healthcare market.
Fundamentals
| Revenue (TTM) | $84.38M |
| Gross Profit (TTM) | $-7.13M |
| EBITDA | $24.91M |
| Operating Margin | -39.40% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $27.64 |
| Price-to-Book | 25.33 |
| Price-to-Sales (TTM) | 31.95 |
| EV/Revenue | 31.56 |
| EV/EBITDA | 105.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $143.09M |
| Float | 81,670 |
| % Insiders | 97.57% |
| % Institutions | 0.95% |
Historical Volatility
HV 10-Day
179.41%
HV 20-Day
149.85%
HV 30-Day
139.06%
HV 60-Day
112.98%
HV Rank
—
Volatility is currently expanding
More TECHNOLOGY Stocks
Data last updated: 6/13/2026